| Financial Year |
March 31 2023 |
| Monetary Funds |
317,364,051.68 |
| Held-for-trading Financial Assets |
50,000,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
253,499,449.54 |
| Advances to Suppliers |
4,169,800.76 |
| Other Receivables |
6,211,888.17 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
186,387,720.39 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,882,643.31 |
| Total Current Assets |
843,023,603.78 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
246,576,627.90 |
| Under-construction Projects |
12,053,170.59 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,390,706.05 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,877,247.09 |
| Deferred Income Tax Assets |
4,340,948.13 |
| Other Non-Current Assets |
27,108,877.00 |
| Sub-Total of Non-Current Assets |
340,922,765.47 |
| Total Assets |
1,183,946,369.25 |
| Short-Term Loans |
70,060,044.44 |
| Trading Financial liabilities |
1,153,704.75 |
| Notes Payable |
-- |
| Accounts Payable |
108,926,831.03 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,626,779.97 |
| Taxes Payable |
2,756,055.81 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
3,301,369.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,706,092.93 |
| Other Current Liabilities |
183,663.69 |
| Sub-Total of Current Liabilities |
240,132,930.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,145,350.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,758,586.35 |
| Total Liabilities |
251,891,517.09 |
| Paid-In Capital(Or Share Stock) |
219,493,931.00 |
| Capital Surplus |
204,130,010.75 |
| Surplus Reserve |
61,322,164.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
445,117,390.83 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
932,054,852.16 |
| Owner's Equity（Stockholder's Equity） |
932,054,852.16 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,183,946,369.25 |
